Literature DB >> 3169993

Clinical, histopathological, and immunological responses of ponies to Ehrlichia sennetsu and subsequent Ehrlichia risticii challenge.

Y Rikihisa1, C I Pretzman, G C Johnson, S M Reed, S Yamamoto, F Andrews.   

Abstract

Ehrlichia risticii has a close antigenic relationship to E. sennetsu. Sera of ponies experimentally infected with E. risticii, the etiologic agent of Potomac horse fever, consistently reacted with E. sennetsu, a human pathogen, in indirect fluorescent-antibody (IFA) testing, while human E. sennetsu convalescent serum reacted with E. risticii by IFA testing and immunoferritin labeling of cells infected in vitro. Two ponies injected intravenously with live E. sennetsu did no develop clinical illness. Subsequent injection with live E. sennetsu did not develop clinical illness. Subsequent injection with live E. risticii also did not induce any disease, in contrast to two control ponies given E. risticii without prior exposure to E. sennetsu. Both controls developed fever, anorexia, depression, dehydration, and diarrhea, which are typical clinical signs of Potomac horse fever, and had characteristic lesions of enteritis and lymph node histiocytosis at postmortem examination. E. sennetsu-exposed ponies had normal gastrointestinal morphologies and lymph node hyperplasia. Ponies primed with E. sennetsu before E. risticii challenge developed high titers of immunoglobulin G antibody which reacted against both E. sennetsu and E. risticii antigens by IFA testing. The most prominent antigenic polypeptide in Western (immuno-) blot analysis of sera collected from ponies primed with E. sennetsu before subsequent challenge with E. risticii was present in lysates of both Ehrlichia species and had an apparent molecular mass of 44 kilodaltons. This band was not prominent in Western blots performed with sera of ponies injected with E. risticii alone. Thus, injection of E. sennetsu protects ponies from clinical and pathological manifestations of the disease induced by injection with E. risticii. Immunologic cross-reactivity of the two organisms with IFA testing and strong immunologic recognition by ponies of the 44-kilodalton antigen common to the two organisms may be related to the development of protective immunity against E. risticii.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3169993      PMCID: PMC259677          DOI: 10.1128/iai.56.11.2960-2966.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Persistent infection of Rickettsia sennetsu in cell culture system.

Authors:  Y Minamishima
Journal:  Jpn J Microbiol       Date:  1965-06

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Enzyme-linked immunoelectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis.

Authors:  V C Tsang; J M Peralta; A R Simons
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

5.  Adaptation of Ehrlichia sennetsu to canine blood monocytes: preliminary structural and serological studies with cell culture-derived Ehrlichia sennetsu.

Authors:  C J Holland; M Ristic; D L Huxsoll; A I Cole; G Rapmund
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

6.  Changes in immunoferritin labeling of Rickettsia tsutsugamushi after serial cultivation in 60Co-irradiated BHK cells.

Authors:  Y Rikihisa; T Rota; T H Lee; A B MacDonald; S Ito
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

7.  Host defenses in experimental scrub typhus: role of cellular immunity in heterologous protection.

Authors:  A Shirai; P J Catanzaro; S M Phillips; J V Osterman
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

8.  Isolation, experimental transmission, and characterization of causative agent of Potomac horse fever.

Authors:  C J Holland; M Ristic; A I Cole; P Johnson; G Baker; T Goetz
Journal:  Science       Date:  1985-02-01       Impact factor: 47.728

9.  Ultrastructural study of ehrlichial organisms in the large colons of ponies infected with Potomac horse fever.

Authors:  Y Rikihisa; B D Perry; D O Cordes
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

10.  Serological cross-reaction and cross-protection in guinea pigs infected with Rickettsia rickettsii and Rickettsia montana.

Authors:  W C Feng; J L Waner
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

View more
  21 in total

1.  Comparison of PCR and culture to the indirect fluorescent-antibody test for diagnosis of Potomac horse fever.

Authors:  J Mott; Y Rikihisa; Y Zhang; S M Reed; C Y Yu
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Analysis of p51, groESL, and the major antigen P51 in various species of Neorickettsia, an obligatory intracellular bacterium that infects trematodes and mammals.

Authors:  Yasuko Rikihisa; Chunbin Zhang; Manuel Kanter; Zhihui Cheng; Norio Ohashi; Takeo Fukuda
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

3.  Passive transfer of antibody to Ehrlichia risticii protects mice from ehrlichiosis.

Authors:  P S Kaylor; T B Crawford; T F McElwain; G H Palmer
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 4.  An overview of research on ehrlichiosis.

Authors:  M Ristic; C J Holland; M Khondowe
Journal:  Eur J Epidemiol       Date:  1991-05       Impact factor: 8.082

5.  Antigenic characterization of ehrlichiae: protein immunoblotting of Ehrlichia canis, Ehrlichia sennetsu, and Ehrlichia risticii.

Authors:  P Brouqui; J S Dumler; D Raoult; D H Walker
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

6.  Anti-Ehrlichia chaffeensis antibody complexed with E. chaffeensis induces potent proinflammatory cytokine mRNA expression in human monocytes through sustained reduction of IkappaB-alpha and activation of NF-kappaB.

Authors:  E H Lee; Y Rikihisa
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

7.  Inhibition of binding, entry, or intracellular proliferation of Ehrlichia risticii in P388D1 cells by anti-E. risticii serum, immunoglobulin G, or Fab fragment.

Authors:  J B Messick; Y Rikihisa
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Production and characterization of Ehrlichia risticii, the agent of Potomac horse fever, from snails (Pleuroceridae: Juga spp.) in aquarium culture and genetic comparison to equine strains.

Authors:  G H Reubel; J E Barlough; J E Madigan
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

9.  Cytopathic effect, plaque formation, and lysis of Ehrlichia chaffeensis grown on continuous cell lines.

Authors:  P Brouqui; M L Birg; D Raoult
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

Review 10.  The tribe Ehrlichieae and ehrlichial diseases.

Authors:  Y Rikihisa
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.